SNPs. The TCR-mediated signaling was analyzed with the downstream signaling molecules ZAP-70 and IL-2. Results: This study revealed that an A391C polymorphism is the only mutant related to the binding. Jurkat T cells transfected with the A391C mutant reduced the inhibition of ZAP-70 phosphorylation and IL-2 production compared to cells transfected with the wild type. Conclusions: Siglec-9 A391C was the only polymorphism related to TCR-mediated signaling in human Siglec-9, resulting in less inhibition compared to the wild type.
CD33-related Siglecs seem to be evolving rapidly, and there are 9 CD33-related Siglecs and 1 Siglec-like protein in humans. An important function of the CD33-related Siglecs is their ability to regulate cell growth and survival, either by inhibition of proliferation or induction of apoptosis. Most CD33-related Siglecs have 1 or more immunoreceptor tyrosine-based inhibitory motifs in their cytoplasm tail [2] for the recruitment of Src homology region 2 domain-containing phosphatase (SHP)-1 and SHP-2 and for inhibitory signaling functions [3] [4] [5] . The structure of the CD33-related Siglec-7 has been determined, and it provides a structural prototype for the other members of this family including Siglec-9 [6] .
Siglecs have a cell type-specific expression, and the recent identification of Siglec-9 is strongly expressed as Siglec-7 on neutrophils and less so on monocytes, NK cells [5] , and B and T cells [12, 13] . In neutrophils, the antibody-induced ligation of Siglec-9 induces cell death [7] , which has been shown to be responsible for the cytokine-dependent cytotoxic effect of intravenous Ig on inflammatory cells including neutrophils [8] . Intravenous Ig has been used for the treatment of autoimmune and systemic inflammatory diseases [9] [10] [11] . Siglec-9 in macrophages has induced anti-inflammatory cytokine and interleukin (IL)-10 production [14] to suppress excess proinflammatory cytokine production which is harmful to the host [15] . In T cells, it regulates T cell receptor (TCR) activation by the recruitment of SHP-1, resulting in reduced transcription of the nuclear factor of activated T cell (NFAT)-mediated cytokine gene as Siglec-7 [16] . In fact, human-specific loss of T cell Siglec expression has been shown to be associated with T cell hyperactivity, whereas transfection of Siglec-7 and Siglec-9 into the Jurkat T cell line inhibits TCR-mediated signaling [17] . Thus, Siglec-9 is emerging as an important regulator of the immune system.
The inhibitory functions of Siglec-9 as well as Siglec-7 have been demonstrated by site-directed mutagenesis [5] . Studies on Siglec polymorphisms among humans have been proposed on the basis of a growing number of data linking inhibitory receptor polymorphisms and autoimmune diseases [18] . In human Siglec-9, at least 8 nonsynonymous SNPs, including rs1697545, rs2075803, rs200658, rs16988910, rs273687, rs2258983, rs273688, and rs273690 (dbSNP accession No.), have been detected. However, there have been no functional studies on any of them. The functions of Siglecs are modulated by their interaction with sialic-acid-containing carbohydrate groups of glycoproteins and glycolipids as ligands. Particularly, the C-C' loop in the sugar-binding domain plays a major role in determining the binding specificities of Siglec-7 and Siglec-9 [19] .
In this study, we examined carbohydrate binding affinity with a molecular modeling analysis [6, 20] and an RBC binding assay using the 8 mutants. Both results showed that the changed amino acid residue in the A391C polymorphism (dbSNP accession No. rs16988910) could be the only mutant affected in terms of binding affinity. In the functional study of the mutant, an increased ZAP-70 phosphorylation in the variant compared with the wild type was confirmed, along with a reduced inhibition of NFAT-mediated cytokine gene transcription such as IL-2 production in transfected Jurkat cells.
Materials and Methods

Analysis of the Siglec-9 Homology Model Structure
To investigate a possible relationship between the A391C polymorphisms identified in Siglec-9, we used a 3-dimensional (3D) model of the Siglec-9 protein constructed based on the crystal structure of Siglec-7. The sequence alignment of Siglec-9 and Siglec-7 was generated using FASTA software (http://www.ebi. ac.uk/fasta33). A 3D model structure of Siglec-9 was built using the HOMOLOGY module of Insight II (Accelrys Software, Inc., San Diego, Calif., USA) and was further refined by using the Discover version 2.98 program of Insight II. The 3D model structure of Siglec-9 was visualized with PYMOL (http://www.pymol.org).
The Siglec-9 and carbohydrate docking model was generated by superposing the Siglec-7 and carbohydrate complex and by using an X-ray structure with PDB code 1RVT.
Cell Culture
Jurkat cells (No. 40152; KCLB, Seoul, South Korea) were cultured in RPMI 1640 (WelGENE, Inc., Daegu, South Korea) supplemented with 10% heat-inactivated fetal bovine serum (WelGENE), 100 units/ml of penicillin and 100 units/ml of streptomycin (Invitrogen, Carlsbad, Calif., USA). COS-7 cells (No. 21651; KCLB) were cultured in DMEM (Invitrogen) supplemented with 10% fetal bovine serum, 100 units/ml of penicillin and 100 units/ml of streptomycin.
Expression Constructs
The entire coding sequence of Siglec-9 was amplified by PCR using a Siglec-9 clone purchased from the 21C Human Gene Bank, Genome Research Center, KRIBB (South Korea), as a template. The PCR product was inserted into the pcDNA3 vector (Invitrogen). Eight mutant constructs of Siglec-9, including rs1697545 (Y45 * ), rs2075803 (K100E), rs200658 (S125N), rs16988910 (K131Q), rs273687 (N147K), rs2258983 (A315E), rs273688 (A316D), and rs273690 (V349A), were prepared by inverse PCR.
Transient Expression of Siglec-9 and the Mutants
After having been washed with RPMI 1640 and resuspended in a Nucleofector Kit V (Amaxa, Cologne, Germany), the Jurkat cells were nucleofected according to the manufacturer's guidelines. Briefly, a 100-l suspension of 4 ! 10 6 cells mixed with 7 g of each plasmid DNA was transferred to the provided cuvette and nucleofected with a Nucleofector apparatus on the S-018 program setting. The cells were immediately transferred into wells in 60-mm dishes, which contained culture medium prewarmed to 37 ° C.
The COS-7 cells were transfected with the vectors using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Briefly, 4 l per well of Lipofectamine 2000 and 1.6 g of plasmid DNA were diluted in Optimem (Invitrogen). Five hours after the transfection, all cells were cultured for another 48 h and flow cytometry analysis was then performed.
Flow Cytometry Analysis
Surface expressions of the wild-type and mutant cells were evaluated by flow cytometry after direct staining with FITC-labeled anti-human Siglec-9 and mouse IgG1-(BD Biosciences, San Jose, Calif., USA). The cultured cells were washed with Dulbecco's phosphate-buffered saline (PBS) solution containing 0.1% bovine serum albumin and then incubated with FITC-labeled anti-Siglec-9 or IgG1-antibodies at 4 ° C for 30 min. The labeled cells were analyzed with a Cytomics TM FC500 flow cytometer (Beckman Coulter, Hialeah, Fla., USA) using CXP software (Beckman Coulter).
RBC Binding Assay
Human blood was obtained from healthy volunteers. After centrifugation at 500 g , the RBCs were washed 3 times with PBS buffer. Binding assays were performed 2 days after the transfection of Siglec-9 and the mutants into the COS-7 cells. Then, 10 l of compacted RBCs was resuspended with 490 l of 0.05 M HEPES buffer and added to the COS-7 cells, which had been pretreated with 10 mU of neuraminidase (Sigma, St. Louis, Mo., USA) for 30 min at 37 ° C. After incubation, the unbound RBCs were removed with 3 PBS washes, and the bound RBCs were examined immediately under an inverted microscope (Leica, Wetzlar, Germany). Ten random fields were photographed for the 3 independent experiments. The number of RBC rosettes, which were defined as COS-7 cells binding more than 5 RBCs per field, was counted in 30 fields. The data were analyzed using an unpaired t test (SPSS 13.0 software) and considered statistically significant if p ! 0.05.
Western Blot Analysis
Jurkat cells (2 ! 10 6 ) were incubated either for 20 min with 5 g/ml of anti-CD3 antibody or for 10 min with 20 ng/ml of phorbol 12-myristate 13-acetate (PMA; Sigma). The cells were then homogenized in ice-cold homogenization buffer. Equal amounts (30 g) of the extracted protein were resolved with 8% SDS-PAGE and transferred to nitrocellulose membranes. After incubation in a blocking solution, the membranes were incubated overnight at 4 ° C with 1: 1,000 diluted anti-phospho-ZAP-70 and anti-ZAP-70 antibodies (rabbit polyclonal; Cell Signaling Technology, Beverly, Mass., USA). The membranes were then further incubated with anti-rabbit horseradish peroxidase-conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, Calif., USA) and treated with an enhanced chemiluminescence solution (Pierce kit; Rockford, Ill., USA). The signals were then captured on an Image Reader (LAS-3000; Fuji Photo Film, Tokyo, Japan), and the protein bands were analyzed using Multi Gauge version 3.0 software (Fuji Photo Film).
IL-2 Expression Level Measurement
For the stimulation experiments, the Jurkat cells (1 ! 10 6 ) were cultured with 20 ng/ml of PMA and 1 M of ionomycin (Calbiochem, La Jolla, Calif., USA) for the indicated period. Total RNA from the Jurkat cells, cultured under each condition, was obtained with Trizol Reagent (Invitrogen). Reverse transcription of the RNA was performed using a First Strand cDNA Synthesis Kit for RT-PCR (AMV; Boehringer Mannheim, Germany). The level of IL-2 mRNA relative to GAPDH was measured by quantitative real-time PCR using the LightCycler real-time PCR System (Roche). The primers used were as follows: IL-2: 5 -CACCAG-GATGCTCACATTTAAGTT-3 (forward) and 5 -GTGTCCTGA-GTTCTTCTTCTAGACACT-3 (reverse); GAPDH: 5 -TCCACT-GGCGTCTTCACC-3 (forward) and 5 -GGCAGAGATGATGAC CCTTT-3 (reverse).
To measure the amount of IL-2 at the protein level, the culture supernatants were collected and stored at -70 ° C. The level of IL-2 was measured using commercial ELISA kits (R&D Systems, Minneapolis, Minn., USA) according to the manufacturer's instructions.
Results
Involvement Only of the A391C (K131Q) Mutant in the Carbohydrate Binding
In human Siglec-9, 8 nonsynonymous SNPs have been reported without functional studies. In this study, we examined the position of these 8 SNPs by homology modeling. The plausible homology model structure of Siglec-9 is presented in figure 1 a. The location of the SNPs was predicted for only 4 residues; K100E, S125N and K131Q could be located in the carbohydrate recognition domain and N147K could be positioned in the Ig-like domain. In the case of the K131Q residue, it could directly interact with a carbohydrate molecule, whereas the K100E and S125N residues could not interact with carbohydrates, even if these residues were positioned in the carbohydrate recognition domain.
The docking model of Siglec-9 and the carbohydrate was generated ( fig. 1 b) . The wild-type Lys 131 side chain could form a hydrogen bond with a hydroxyl group of the carbohydrate molecule, whereas the Gln 131 mutant could have a weak hydrogen bond interaction with a hydroxyl group of the carbohydrate molecule.
Reduced RBC Binding of K131Q-Transfected COS-7 Cells
To investigate their ability to bind with sialic acid in human RBCs, the COS-7 cells were transiently transfected with the full-length wild-type Siglec-9 or the 8 mutants K131Q, K100E, S125N, N147K, A315E, A316D, V349A, and Y45 * . Before comparing the binding activity of the wild type and the mutants, the expression levels from the transient transfection were confirmed to be similar in the wild-type-and mutant-transfected cells ( fig. 2 a) . In one mutant, Y45 * , full-length Siglec-9 was not formed because the tyrosine residue was changed into a termination codon. The only mutant in which transfected cells showed significantly (p = 0.002) reduced binding with RBCs compared to the wild type was K131Q ( fig. 2 b, c) .
Increased ZAP-70 Phosphorylation and IL-2 Production by K131Q
Siglec-9 has been shown to negatively regulate TCR signaling associated with ligand binding [16] . The engagement of TCR leads to the transcription of immune response genes, such as IL-2, through ZAP-70, a Syk kinase [21, 22] . Therefore, the effects of wild-type Siglec-9 and K131Q on TCR signaling were evaluated by the analysis of (1) phosphorylation of Tyr 319 with ZAP-70 and (2) the production of IL-2.
The expression levels of each gene were similar in comparisons between the Jurkat cells transiently transfected with the wild type and those with the mutant ( fig. 3 a) . The induction of TCR engagement, with anti-CD3 (5 g/ml) or PMA (50 ng/ml) [23] in the transfected Jurkat cells, showed that the phosphorylation of ZAP-70 Tyr 319 increased in the mutant K131Q-expressing cells compared to the wild-type-expressing cells ( fig. 3 b, c) .
Production of the immune response gene IL-2 was compared in the transfected cells with PMA stimulation by quantitative real-time PCR and ELISA. In the levels of mRNA expression, a markedly reduced inhibition was de- m. c The data represent the mean 8 SD of the number of RBC rosettes in the wild type and mutants. Significantly less binding was observed only in the K131Q mutant. * p ! 0.005 was analyzed using an unpaired t test. tected in the K131Q cells compared to the wild-type-transfected cells ( fig. 4 a) . The levels of protein expression showed patterns similar to those of the mRNA expression ( fig. 4 b) .
Discussion
The results of this study demonstrate the novel function of SNP on the ligand binding site of Siglec-9 through a molecular modeling analysis, RBC binding assay, and TCR signaling analysis. One of the 8 mutants, which had the amino acid lysine residue (Lys 131 ) changed to a glutamine residue (Gln 131 ) and was speculated to interact directly with a carbohydrate molecule resulted in reduced RBC binding, with increased ZAP-70 phosphorylation and IL-2 production compared to the wild-type gene, indicating a reduced inhibition of immune reactions.
Analysis of the Siglec-9 homology model structure revealed that 4 amino acid residues of the 8 SNPs were in the binding sites. Among them, N147K was located in the Ig-like domain but not in the carbohydrate binding domain, and 2 SNPs, K100E and S125N, did not contribute to carbohydrate binding, although they were included in the carbohydrate recognition domain. In the mutant (db-SNP accession No. rs16988910) in which amino acid Lys(K) 131 changes into Gln(Q) 131 , the length of the Lys(K) 131 side chain seemed to be long enough to make a tight hydrogen bond with the galactose ring, whereas that of the Gln(Q) 131 side chain did not, resulting in a reduction of the binding affinity to the ligand. Similar results could be inferred from the study results of Siglec-7; the structure of this CD33-related Siglec has been determined [6] and it represents a good candidate for structure-based inhibitor design in site-directed mutagenesis and binding assays. The mutagenesis and binding assays of Siglec-7 have shown that residues Asn 133 and Lys 135 may play a genuine role in ligand binding [24] . The mutation of residues including Lys 135 into alanine has been shown to lose the ability to bind [25] . The mutation of Lys 135 of Siglec-7 is applicable to Lys 131 of Siglec-9 in terms of the alignment [26] , although the A391C polymorphism changed amino acid residue Gln 131 . RBC binding was significantly (p = 0.002) inhibited in the only mutant Gln 131 transfected into the COS-7 cells, as was the expected result in the molecular modeling analysis ( fig. 2 ). The result showing that an active ligand domain is required whenever Siglec-9 negatively regulates TCR signaling at multiple steps in the signaling pathway [16] may suggest that the K131Q mutant could reduce the inhibition of TCR activation. Jurkat cells are known to be ideal for the analysis of the effects of Siglec-9 on TCR signaling because there is no Siglec-9 expression on the cells. However, TCR signaling may not be significant for the analysis of Siglec-9 effects because Siglec-9 is not expressed by most T cells. Nonetheless, this study focused on the binding activity of the mutants to sialic acid. Moreover, the sialic-acid-binding activity regulated by Siglec-9 has been examined only through TCR signaling in Jurkat cells [16] , which is why Jurkat cells were used for this study. TCR activation recruits and activates ZAP-70, a Syk kinase. TCR is composed of TCR and CD3 dimers, and TCR engagement has induced only anti-CD3 [16] . Treatment with PMA, a direct activator of protein kinase C, also triggers TCR through the activation of Ras in T cells [27] . Moreover, treatment with either the anti-CD3 antibody ( fig. 3 b) or PMA plus calcium ionophore ( fig. 3 c) activated ZAP-70 in this study. Since Siglec-9 after ligand binding downregulates TCR activation by the recruitment of SHP-1 [16] , the reduced binding would be expected to less inhibit ZAP-70 phosphorylation at Tyr 319 [16] . In fact, the inhibition levels of ZAP-70 phosphorylation in the mutant K131Q-transfected Jurkat cells were significantly lower than those of the wildtype gene-transfected cells, regardless of the treatment method (anti-CD3 or PMA plus ionophore) ( fig. 3 b, c) .
The end product of ZAP-70 phosphorylation is the NFAT-mediated transcription of immune response genes, such as IL-2 or IFN-␥ [8] . However, treatment with the anti-CD3 antibody alone was not enough to measure IL-2 (data not shown). Although CD28 costimulation plays an essential role in IL-2 production in primary T cell activation [28, 29] , it was not investigated in this study. Instead of CD28 stimulation, treatment with PMA plus calcium ionophore was tried since protein kinase C-dependent activation of the Ras signal transduction cascade has been reported to be essential for the induction of the IL-2 promoter during the stimulation of T cells via the TCR [30] . In fact, the production of IL-2 was confirmed on both mRNA ( fig. 4 a) and protein ( fig. 4 b) levels. Moreover, the K131Q mutant inhibited IL-2 production less compared to the wild type ( fig. 4 ) . Overall, this study showed that mutant A391C (K131Q) of Siglec-9 reduced sialic-acid-ligand-binding as well as the inhibition of TCR-mediated signaling represented by ZAP-70 phosphorylation and IL-2 production compared to the wild type.
